Drug Shortage Report for CIPRO ORAL SUSPENSION
| Report ID | 229988 |
| Drug Identification Number | 02237514 |
| Brand name | CIPRO ORAL SUSPENSION |
| Common or Proper name | CIPROFLOXACIN SUSPENSION |
| Company Name | BAYER INC |
| Market Status | MARKETED |
| Active Ingredient(s) | CIPROFLOXACIN |
| Strength(s) | 500MG |
| Dosage form(s) | SUSPENSION |
| Route of administration | ORAL ORAL |
| Packaging size | 10g/100mL |
| ATC code | J01MA |
| ATC description | QUINOLONE ANTIBACTERIALS |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | 2024-07-01 |
| Actual start date | 2024-07-03 |
| Estimated end date | 2024-07-16 |
| Actual end date | 2024-07-15 |
| Shortage status | Resolved |
| Updated date | 2024-07-16 |
| Company comments | Supply delay |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2920 MATHESON BLVD EAST MISSISSAUGA, ONTARIO CANADA L4W 5R6 |
| Company contact information | 1-800-265-7382 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v17 | 2024-07-16 | English | Compare |
| v16 | 2024-07-15 | French | Compare |
| v15 | 2024-07-15 | English | Compare |
| v14 | 2024-07-12 | French | Compare |
| v13 | 2024-07-12 | English | Compare |
| v12 | 2024-07-04 | English | Compare |
| v11 | 2024-07-03 | French | Compare |
| v10 | 2024-07-03 | English | Compare |
| v9 | 2024-07-03 | French | Compare |
| v8 | 2024-07-03 | English | Compare |
| v7 | 2024-07-02 | English | Compare |
| v6 | 2024-06-19 | French | Compare |
| v5 | 2024-06-19 | English | Compare |
| v4 | 2024-06-07 | French | Compare |
| v3 | 2024-06-07 | French | Compare |
| v2 | 2024-06-07 | English | Compare |
| v1 | 2024-06-07 | English | Compare |
Showing 1 to 17 of 17